Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer

for
Metastatic Oropharyngeal Carcinoma,
Location: Nashville TN, Birmingham AL
Sponsor: Michael K. Gibson

Sex: All

Age: 18+

Code: NCT05799144

Phase2, Recruiting

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

for
Relapsed Myelodysplastic Syndrome,
Location: Nashville TN, Memphis TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06399640

Phase1, Recruiting

EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing

for
Lung Cancer
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06105801

Recruiting

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

for
Advanced Lung Neuroendocrine Tumor,
Location: Nashville TN, St Louis MO, Columbus OH, New Lenox IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04665739

Phase2, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Nashville TN, Chattanooga TN, Knoxville TN,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Eben Rosenthal

Sex: All

Age: 19+

Code: NCT05747625

Phase1, Recruiting

Genetics of Appendix Cancer Study

for
Appendix Cancer, Appendiceal Cancer, Appendiceal Neoplasms,
Location: Nashville TN
Sponsor: Andreana Holowatyj, PhD, MSCI

Sex: All

Age: 18+

Code: NCT05734430

Recruiting

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Nashville TN, Cleveland OH, Dallas TX, Duarte CA,
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05361720

Phase2, Recruiting

Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

for
Head and Neck Cancer, Locally Advanced Head and Neck Carcinoma
Location: Nashville TN
Sponsor: Natalie Lockney

Sex: All

Age: 21+

Code: NCT05156060

Phase1, Phase2, Recruiting

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

for
Clinical Stage III Gastric Cancer AJCC v8,
Location: Nashville TN, Jacksonville FL, Green Bay WI, Weston FL,
Sponsor: Academic and Community Cancer Research United

Sex: All

Age: 18+

Code: NCT04660760

Phase2, Recruiting

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

for
Metastatic HER2-Negative Breast Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT05770531

Phase2, Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

for
Relapsed or Refractory T Cell Lymphoma
Location: Nashville TN, Atlanta GA, St Louis MO, Charlotte NC,
Sponsor: Ono Pharmaceutical Co. Ltd

Sex: All

Age: 18+

Code: NCT05079282

Phase1, Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

for
Melanoma (Skin Cancer),
Location: Nashville TN, Cincinnati OH, Detroit MI, Fairway KS,
Sponsor: Aminex Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07287917

Phase1, Phase2, Recruiting

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Nashville TN, Charlotte NC, Concord NC, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06661915

Phase2, Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

for
Astrocytoma, IDH-Mutant, Grade 2,
Location: Nashville TN, Lexington KY, Atlanta GA, Charlotte NC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06860594

Phase1, Recruiting

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

for
Breast Cancer (Triple Negative Breast Cancer (TNBC)),
Location: Nashville TN
Sponsor: Jessica Mezzanotte Sharpe

Sex: All

Age: 18+

Code: NCT07555210

Recruiting

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Nashville TN, Knoxville TN, Louisville KY, Atlanta GA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06769698

Phase2, Recruiting

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

for
Gastric Adenocarcinoma,
Location: Nashville TN, Atlanta GA, Lexington KY, Shiloh IL,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT07001748

Phase2, Phase3, Recruiting

A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

for
Advanced Renal Cell Carcinoma (aRCC),
Location: Nashville TN, Chapel Hill NC, Milwaukee WI,
Sponsor: Brian Rini

Sex: All

Age: 18+

Code: NCT07188896

Phase2, Recruiting

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Nashville TN, Atlanta GA, Effingham IL, Shiloh IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07195734

Phase2, Recruiting